Clinical Trial Update: GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

View source ↗

Summary

Clinical trial update for the GLORIA-AF Registry Program (Phase II/III) in EU/EEA showing completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Stroke, Atrial Fibrillation | Status: COMPLETED | Results posted: 2020-12-31